Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Philips to Acquire Agilent's Medical Unit for $1.7 Billion

By HospiMedica staff writers
Posted on 22 Nov 2000
Royal Philips Electronics (Amsterdam, The Netherlands) has agreed to acquire the Healthcare Solutions Group (HSG) of Agilent Technologies for US$1.7 billion. The acquisition will expand the scope of Philips Medical Systems (PMS) and enable the company to enter new, high-growth market segments that include automatic external defibrillators (AEDs) and home care technology with remote diagnostics. With annual sales of $1.5 billion, HSG has strong positions in the markets it serves.

The HSG portfolio will complement the PMS line, adding patient monitoring devices, ultrasound imaging, and AEDs and other resuscitation aids. HSG also markets information management and other services and supplies.

Agilent Technologies was created in 1999 as a spinoff of Hewlett Packard Corp. and consists of two business groups, HSG and a test and measurement group. In August of this year, Agilent announced a major global restructuring program to improve operational performance.

PMS is a leading supplier of diagnostic imaging systems, including magnetic resonance imaging (MRI), computed tomography (CT), catheterization labs, x-ray, and ultrasound. The company has invested more than $4 billion in its medical systems business over the past two years, most recently agreeing to buy nuclear medicine company Adac for $426 million.

"By combining the two companies' ranges of products and services, we will be able to offer our customers more disease-specific solutions, helping to improve patient outcome and efficiency,” said Hans Barella, president and CEO of Philips Medical System.





Related Links:
Agilent
Philips
Mobile X-Ray System
K4W
Computed Tomography System
Aquilion ONE / INSIGHT Edition
Breast Localization System
MAMMOREP LOOP
High-Precision QA Tool
DEXA Phantom

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.